Also trades as: AJANTPHARM.BO (BSE) · $vol 0M
AJANTPHARM.NS NSE
Ajanta Pharma Limited
1W: +1.2%
1M: +2.2%
3M: +7.7%
YTD: +23.9%
1Y: +35.5%
3Y: +111.8%
5Y: +150.5%
₹3,492.50 ($36.27)
-88.50 (-2.47%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$5.2B
-55.4% ▼
5Y CAGR: -2.2%
Capital Expenditures
$3.7B
-14.9% ▼
5Y CAGR: +16.3%
Free Cash Flow
$1.5B
-82.0% ▼
5Y CAGR: -17.9%
Dividends Paid
$3.5B
-0.1% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$714M
-255.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $9.1B | $7.5B | $8.2B | $9.2B | $10.6B |
| Depreciation & Amort. | $1.3B | $1.3B | $1.4B | $1.4B | $1.7B |
| Stock-Based Comp. | $3M | $2M | $55M | $39M | $0 |
| Change in Working Capital | -$2.0B | $665M | -$1.4B | $1.8B | -$6.5B |
| Other Non-Cash Items | $102M | $55M | -$314M | -$901M | -$598M |
| Operating Cash Flow | $5.6B | $7.9B | $7.9B | $11.6B | $5.2B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.5B | -$1.7B | -$1.5B | -$3.2B | -$3.7B |
| Acquisitions (Net) | $184M | $184M | $0 | $11M | $54M |
| Investment Purchases | -$10.6B | -$16.7B | -$20.8B | -$27.7B | -$26.6B |
| Investment Sales | $10.9B | $12.8B | $22.6B | $26.6B | $25.5B |
| Other Investing | $276M | -$128M | $404M | $441M | $454M |
| Investing Cash Flow | -$741M | -$5.6B | $654M | -$3.8B | -$4.3B |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | -$5M | $600K | $11M | $2.1B |
| Stock Repurchased | -$2.9B | -$14M | -$3.9B | -$3.5B | $0 |
| Dividends Paid | -$822M | -$897M | -$6.4B | -$3.5B | -$3.5B |
| Other Financing | -$925M | -$162M | -$198M | -$338M | -$148M |
| Financing Cash Flow | -$4.6B | -$1.1B | -$10.5B | -$7.3B | -$1.6B |
| Net Change in Cash | $289M | $1.3B | -$2.0B | $460M | -$714M |
| Cash End of Period | $2.1B | $3.3B | $1.3B | $1.8B | $1.0B |
| Free Cash Flow | $4.1B | $6.2B | $6.3B | $8.4B | $1.5B |